What is LOPJLB’s current signal on AGMB?

LOPJLB’s latest quantitative signal on AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is BUY. Signals are updated daily.

What market regime is AGMB in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does AgomAb Therapeutics N.V. American Depositary Shares (AGMB) do?

AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist. Its innovative pipeline features several promising candidates, including Ontunisertib (AGMB-129), an orally admini…

Where is AgomAb Therapeutics N.V. American Depositary Shares based / listed?

AgomAb Therapeutics N.V. American Depositary Shares is based in BE, listed on NASDAQ.

AgomAb Therapeutics N.V. (AGMB)

Healthcare · Biotechnology · NASDAQ · BE

$12.82-3.25%Close

BUY

[SCORES & PROFILE]

FUND: 17
VALUE: 8
GROWTH: 47
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-11.8%

REV YoY-

ROE-19.7%

EPS YoY-

ROA-12.3%

GROSS

NET

[VALUATION]

P/E TTM-15.20

P/E FWD-

SECTOR PE22.57

INDUSTRY PE17.06

P/B2.21

P/FCF-

EV/EBITDA-10.39

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E0.43

ALTMAN Z-

CURR RATIO12.88

ND/EBITDA-

BETA1.64

AgomAb Therapeutics N.V. (AGMB)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news